key: cord-0927131-bb43cebx
authors: Rensen, Elena; Pietropaoli, Stefano; Mueller, Florian; Weber, Christian; Souquere, Sylvie; Isnard, Pierre; Rabant, Marion; Gibier, Jean-Baptiste; Simon-Loriere, Etienne; Rameix-Welti, Marie-Anne; Pierron, Gérard; Barba-Spaeth, Giovanna; Zimmer, Christophe
title: Sensitive visualization of SARS-CoV-2 RNA with CoronaFISH
date: 2021-03-15
journal: bioRxiv
DOI: 10.1101/2021.02.04.429604
sha: 73a7c0a785562763b478e348ec85bc50dbbcf350
doc_id: 927131
cord_uid: bb43cebx

The current COVID-19 pandemic is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The positive-sense single-stranded RNA virus contains a single linear RNA segment that serves as a template for transcription and replication, leading to the synthesis of positive and negative-stranded viral RNA (vRNA) in infected cells. Tools to visualize viral RNA directly in infected cells are critical to analyze its replication cycle, screen for therapeutic molecules or study infections in human tissue. Here, we report the design, validation and initial application of fluorescence in situ hybridization (FISH) probes to visualize positive or negative RNA of SARS-CoV-2 (CoronaFISH). We demonstrate sensitive visualization of vRNA in African green monkey and several human cell lines, in patient samples and human tissue. We further demonstrate the adaptation of CoronaFISH probes to electron microscopy (EM). We provide all required oligonucleotide sequences, source code to design the probes, and a detailed protocol. We hope that CoronaFISH will complement existing techniques for research on SARS-CoV-2 biology and COVID-19 pathophysiology, drug screening and diagnostics.

Applicability of CoronaFISH to drug screening 161 We next asked if CoronaFISH can be used to test pharmacological treatments against SARS-162

CoV-2. To this end, we treated SARS-CoV-2 infected Vero cells with Remdesivir, an adenosine 163 nucleoside triphosphate analog that reduces viral replication in vitro by inhibiting the RdRP 164 (Gordon et al, 2020) . We first established an inhibition curve that showed, in our system, an 165 IC50 concentration of 2.8 µM for Remdesivir (Fig EV1c) . We then performed FISH against the 166 positive strand using Atto-488 labeled probes in infected cells left untreated or treated with 10 167 µM of Remdesivir. In untreated samples, 26% of cells (n=143) displayed a strong fluorescence 168 signal (above the 99% threshold defined for n= 273 uninfected cells), as above, whereas 169

Remdesivir-treated cells only showed background signal similar to uninfected cells (0% of 170 n=179 cells above threshold) (Fig 1g,e) . These data suggest that our CoronaFISH probes can 171 be used to test molecules for their ability to inhibit SARS-CoV-2 replication. 172

Detection of SARS-CoV-2 RNA in human cell lines 173 We next tested the probes in several human cell lines known to be permissive to SARS-CoV-2 174 (Takayama, 2020 We then performed FISH against the positive RNA strand. As for the Vero cells above, the 183 uninfected controls of all human cell types showed only a weak background signal, while a 184 strong signal could be detected in the infected cells (Fig 2a-c) . However, depending on the cell-185 type, the number of infected cells, as well as the amount and cellular localization of vRNA 186 detected by CoronaFISH were very different, consistent with different replication dynamics of 187 SARS-CoV-2 in these cell lines. In Caco-2 cells, only a minority of cells appeared infected (19% 188 of n=1,752 cells above intensity threshold defined from n=229 uninfected cells as above), 189 displaying rather low-intensity values, indicating a low abundance of positive-strand viral RNA 190 (6.2-fold above threshold, s.d. 6.8). Huh7 cells were more permissive for viral infection 191 manifesting in more cells displaying vRNA (74% of n=546 above threshold defined on n=246 192 uninfected cells) and higher RNA signal intensity (11-fold above threshold, s.d. 10). Lastly, all 193

Calu cells were infected (100% of n=773 cells above threshold defined on n=479 uninfected 194 cells) and the signal intensity was higher than in Caco-2 and Huh7 cells (28-fold above 195 threshold, s.d. 14). These data show that CoronaFISH probes can also be used in cell lines of 196 human origin with similar detection performance as in Vero cells. 197 Detection of SARS-CoV-2 RNA in human tissue 198 Next, we aimed to test if our approach can be used to detect SARS-CoV-2 RNA in samples 199 from patients. The major histopathological finding of the pulmonary system of post mortem 200 COVID-19 patients with acute respiratory distress syndrome (ARDS) is diffuse alveolar damage 201 in the acute or organizing phases. Lung tissue examination mainly shows evidence of intra-202 alveolar hemorrhage and edema with fibrin and hyaline membranes developed on alveolar walls 203 at the acute phase and proliferative and fibrotic lesions in the alveolar septal walls at the 204 organizing phase (Hanley et al, 2020; Bradley et al, 2020) . However, these lesions are common 205 to multiple forms of ARDS and not specific to COVID-19 and do not shed light on the underlying 206 etiology. CoronaFISH therefore has the potential to specifically detect SARS-CoV-2 infection 207 and characterize viral tropism within the tissue. 208 209 As a negative control, we imaged a tissue section sample obtained from a deceased adult 210 patient with diffuse alveolar damage from ARDS prior to the COVID-19 pandemic (see 211 Methods). Histological analysis showed diffuse alveolar damage with an important alveolar 212 hemorrhage, an intra-alveolar and interstitial edema with polymorphic inflammatory infiltrate and 213 the presence of early hyaline membrane adjacent to alveolar walls (Fig EV2a) . When staining 214 this sample with the positive-strand CoronaFISH probes, no strong fluorescent signal was 215 detected, despite the presence of alveolar damage comparable to patients suffering from 216 COVID-19 (Fig EV2 b-c) . 217 218 As a positive control, we used samples from a COVID-19 patient who died 3 days after 219 admission to the intensive care unit. Histological analysis showed diffuse alveolar damage at 220 the organizing phase with intra-alveolar hyaline membranes and fibrin together with interstitial 221 fibrotic lesions with polymorphic inflammatory cell infiltrate of alveolar walls (Fig EV2d) . 222

Whereas histology by itself is not sufficient to diagnose lung tissue infection, CoronaFISH 223 revealed infected cells with large cytoplasmic RNA aggregates (Fig 3a) , illustrating that viral 224 presence can also be detected in tissue sections. Because of the extensive destruction of tissue 225 architecture, determining the affected area of the parenchyma is challenging. However, the cell 226 types (e.g. macrophages or type 2 pneumocytes) infected by SARS-CoV-2 could be revealed by 227

combining CoronaFISH with immunostaining. 228

Motivated by the previous results, we next attempted to detect viral presence in human samples 230 used for COVID-19 diagnostics. Nasal swabs were collected from patients with respiratory 231 symptoms as part of routine care at the Hospital Ambroise Paré (Paris) (Fig 3b) . Samples were 232 screened for the presence of SARS-CoV-2 with RT-PCR. The remainder of the sample not used 233 for diagnostics was deposited on coverglass and we performed CoronaFISH against the 234 positive-strand RNA of SARS-CoV-2. Negative samples (RT-PCR Ct value above detection 235 limit) gave no specific signal, but some areas showed substantially higher background than in 236 the cultured cell lines (Fig EV3) . This background was rather homogenous, and thus distinct 237 from the RNA signal seen so far in infected cells above. However, in a RT-PCR positive sample 238 (Ct value = 21), we detected a strong RNA-FISH signal in a subset of cells (Fig 3c) when 239 staining for the positive strand. Therefore, although a systematic analysis on many more 240 samples will be required to assess specificity and specificity, our CoronaFISH probes may allow 241 the detection of SARS-CoV-2 in patient-derived samples in a clinical setting. 242 In uninfected samples, very few gold particles were detected (Fig 4b) . Manual counting on 267 random fields yielded a mean of only 0.5 +/-0.3 gold particles/μm 2 in nuclear and cytoplasmic 268 areas (n=9 regions, for a total of 94.4 μm 2 ), indicative of low background labeling. Although a 269 much larger number of small particles was visible, their size was consistent with ribosomes 270 rather than gold particles (Fig 4e,f) . In infected cells, gold particles were visible in large 271 numbers at several locations, notably at intracytoplasmic (Fig 4c) and extracellular viral 272 particles (Fig EV4e) , as expected. However, DMVs were the most heavily labelled structures 273 (Fig 4d) , with manual counts of 180 +/-39 gold particles/μm2 in DMV zones, a 360 fold 274 increase over uninfected cells (n=11 regions, for a total of 11.9 μm2). Strikingly, we observed 275 gold particles accumulating along DMV internal 10 nm thick fibers and at the periphery of DMVs 276 (Fig 4d, Fig EV4f) . Although the nature of these fibers remains to be determined, this 277 accumulation of gold particles could reflect a slow export of the viral genomes through the The following day the supernatants to be titered were thawed and serially diluted in tenfold 465 steps in DMEM -Glutamax 1% FBS. 100 ul of the dilutions were used to infect the Vero 466 monolayers, and incubated for 2 h at 37˚C 5% CO2. The infection medium was then discarded 467 and a semi-solid media containing MEM 1X, 1.5% CMC, 10% FBS was added to the 468 monolayers. The cells were incubated at 37˚C 5% CO 2 for 36 hours. Cells were then fixed with 469 4% formaldehyde and foci were revealed using a rabbit anti-SARS-CoV N antibody and 470 matching secondary HRP-conjugated secondary antibodies. Foci were visualized by 471 diaminobenzidine (DAB) staining and counted using an Immunospot S6 Analyser (Cellular 472 Technology Limited CTL). Viral titers were expressed as focus forming units (FFU)/ml. 473

To determine IC50 of Remdesivir in our system, Vero cells were pre-treated with serial dilution 475 of Remdesivir (100nM-100µM) for 1h at 37C before infection with SARS-CoV-2 at MOI 0.02. 476

After 2hs infection the virus inoculum was removed, cells were replenished with drug-containing 477 media and incubated for two days. Supernatant was then collected and titered by focus forming 478 assay. IC50 values were calculated by non linear regression analysis (log(inhibitor) vs response 479 -Variable slope (four parameters)) using Prism 6, GraphPad software. For the FISH experiment 480

Vero cells infected at MOI 0.1 were treated with Remdesivir 10 µM and fixed 24hs p.i. 481 

FISH-Flow, a protocol for the concurrent detection of mRNA and 589 protein in single cells using fluorescence in situ hybridization and flow cytometry

Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 593 Patients

Histopathology and ultrastructural findings of fatal COVID-19 596 infections in Washington State: a case series

Nanoscale imaging of RNA with expansion 599 microscopy

Cytokine Responses in Severe Acute Respiratory Syndrome 602

Coronavirus-Infected Macrophages In Vitro: Possible Relevance to Pathogenesis

Integrative Imaging Reveals SARS-CoV-2-Induced 606 Reshaping of Subcellular Morphologies

Foldscope: Origami-Based Paper Microscope

Coronaviruses: an overview of their replication and pathogenesis

Human Coronavirus: Host-Pathogen Interaction

2020) β-Coronaviruses Use Lysosomes for Egress Instead of the 615 Biosynthetic Secretory Pathway

Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from 618 severe acute respiratory syndrome coronavirus 2 with high potency

Histopathological findings and viral tropism in UK 622 patients with severe fatal COVID-19: a post-mortem study

P-Body Purification Reveals the Condensation of 626 Repressed mRNA Regulons

Validating transcripts with probes and imaging 629 technology

The Architecture

Visualization of Arenavirus RNA Species in Individual Cells by 635

Single-Molecule Fluorescence In Situ Hybridization Suggests a Model of Cyclical 636 Infection and Clearance during Persistence

SARS-CoV-2 structure and replication 639 characterized by in situ cryo-electron tomography

Antibody-dependent enhancement and 641 SARS-CoV-2 vaccines and therapies

Darzacq 643 X & Zimmer C (2013) FISH-quant: automatic counting of transcripts in 3D FISH images

SARS-coronavirus-2 647 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology

ImJoy: an open-source 650 computational platform for the deep learning era

A Growing Toolbox to Image Gene 652 Expression in Single Cells: Sensitive Approaches for Demanding Challenges

Imaging individual 655 mRNA molecules using multiple singly labeled probes

Clustering and reverse transcription of HIV-1 genomes in nuclear niches of 658 macrophages

Multiplexed detection of viral infections using rapid 661 in situ RNA analysis on a chip

Role of the early 663 secretory pathway in SARS-CoV-2 infection

Measuring mRNA copy number in 665 individual Escherichia coli cells using single-molecule fluorescent in situ hybridization

A unifying structural and functional model of 669 the coronavirus replication organelle: Tracking down RNA synthesis

The intracellular sites of early replication and budding of SARS-coronavirus

Cellpose: a generalist algorithm for 675 cellular segmentation

Open-source do-it-yourself multi-color fluorescence 677 smartphone microscopy

Vitro and Animal Models for SARS-CoV-2 research

Coronavirus membrane fusion 681 mechanism offers a potential target for antiviral development

Single-683 mRNA counting using fluorescent in situ hybridization in budding yeast

smiFISH and FISH-quant -a flexible single RNA 687 detection approach with super-resolution capability

Coronavirus biology and replication: 689 implications for SARS-CoV-2

Single Molecule RNA FISH (smFISH) in Whole-Mount Mouse Embryonic 691 Organs

A molecular pore spans the double 694 membrane of the coronavirus replication organelle

RollFISH achieves robust quantification of single-697 molecule RNA biomarkers in paraffin-embedded tumor tissue samples

Design of 240,000 orthogonal 25mer 700 DNA barcode probes

Functional Domains of NEAT1 Architectural lncRNA Induce 703

See Fig EV4e for extracellular 768 aggregates. DMVs were the most heavily labelled structures, and displayed viral RNAs 769 accumulating especially on peripheral 10 nm fibers (d, rightmost frame and Fig EV4f). By 770 contrast, mitochondria or nuclei were not significantly labelled. DMV: double membrane 771 vesicles

(f) Line 773 profiles through the averaged spots in e. The punctate structures visible in infected cells have a 774 size in agreement with the 10 nm nano-gold particles, whereas the punctate structures in 775 uninfected cells are substantially larger and consistent with 30 nm ribosomes